✦ LIBER ✦

Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C

✍ Scribed by S. Zhao; E. Liu; K. Wei; Y. Wang; Y. Li; B. Huang; Y. Chen; P. Yang

Publisher: Springer
Year: 2010
Tongue: English
Weight: 282 KB
Volume: 30
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-010-1051-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

High-dose ribavirin in combination with

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C

✍ Karin Lindahl; Lars Stahle; Annette Bruchfeld; Robert Schvarcz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Excess mortality in patients with advanc

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

✍ Adrian M. Di Bisceglie; Anne M. Stoddard; Jules L. Dienstag; Mitchell L. Shiffma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

for the HALT-C Trial Group Chronic hepatitis C virus infection can cause chronic liver disease, cirrhosis and liver cancer. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial was a prospective, randomized controlled study of long-term, low-dose peginterferon therapy in pa

Re-treatment of chronic hepatitis C with

Re-treatment of chronic hepatitis C with consensus interferon

✍ E. Jenny Heathcote; Emmet B. Keeffe; Samuel S. Lee; Saya V. Feinman; Myron J. To 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Long-term carriage of hepatitis C virus

Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C

✍ Shinichi Kakumu; Kentaro Yoshika; Kazuma Tanaka; Yasuyuki Higashi; Susumu Kuroka 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

## Abstract Studies were undertaken to investigate whether interferon therapy could induce hepatitis C virus (HCV) carriage with normal serum alanine aminotransferase (ALT) values using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 53 patients

Chronic hepatitis C virus patients with

Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon

✍ E. Jenny Heathcote; Stephen James; Kevin D. Mullen; S. C. Hauser; H. Rosenblate; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 1 views

Patients with chronic hepatitis C who have not had a sustained hepatitis C virus (HCV)-RNA response or serum alanine transaminase (ALT) response to a 6-month course of interferon (IFN) may respond to higher dose retreatment with consensus interferon (CIFN). Some nonresponders to initial IFN treatmen